1.Gao L, Kallam A, Shouse G, et al. Polatuzumab vedotin in CNS lymphoma: proof-of-concept study for blood-brain barrier penetration. Blood Adv. 2025 Oct 8:bloodadvances.2025017181.
2.Sun X, Liu J, Wang Y, et al. Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma. Oncotarget. 2017 Jul 25;8(30):49156-49164.